Loading
Latest filing published 30 Dec 2025 for ASCENTAGE PHARMA GROUP INTERNATIONAL.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Lippman Marc E. is a declared insider of Ascentage Pharma Group International, with filings sourced from SEC (Form 4). We count 2 filings, every one of them for a trade on 26 November 2025.
Purchases make up the whole of the open-market record (2 purchases). The amount is not disclosed for 2 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 30 December 2025 with an open-market purchase in Ascentage Pharma Group International. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations